Ran Liu Selected Research

Fibrosis (Cirrhosis)

7/2023	Fufang Shenhua tablet inhibits renal fibrosis by inhibiting PI3K/AKT.
6/2023	Corrigendum to "Long-term environmental levels of microcystin-LR exposure induces colorectal chronic inflammation, fibrosis and barrier disruption via CSF1R/Rap1b signaling pathway" [J Hazard Mater 440 (2022) 129793].
10/2022	Long-term environmental levels of microcystin-LR exposure induces colorectal chronic inflammation, fibrosis and barrier disruption via CSF1R/Rap1b signaling pathway.
10/2022	TGF-β1 peptide-based inhibitor P144 ameliorates renal fibrosis after ischemia-reperfusion injury by modulating alternatively activated macrophages.
1/2021	Etomidate Attenuates the Ferroptosis in Myocardial Ischemia/Reperfusion Rat Model via Nrf2/HO-1 Pathway.
11/2019	A preliminary study of lung abnormalities on HRCT in patients of rheumatoid arthritis-associated interstitial lung disease with progressive fibrosis.
1/2018	Transplantation of bone marrow-derived endothelial progenitor cells and hepatocyte stem cells from liver fibrosis rats ameliorates liver fibrosis.
1/2018	Efficacy of Glecaprevir/Pibrentasvir for 8 or 12 Weeks in Patients With Hepatitis C Virus Genotype 2, 4, 5, or 6 Infection Without Cirrhosis.
1/2018	Glecaprevir-Pibrentasvir for 8 or 12 Weeks in HCV Genotype 1 or 3 Infection.
1/2018	Glecaprevir/pibrentasvir for hepatitis C virus genotype 3 patients with cirrhosis and/or prior treatment experience: A partially randomized phase 3 clinical trial.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ran Liu Research Topics

Disease

96	Neoplasms (Cancer) 05/2024 - 11/2008
26	Inflammation (Inflammations) 05/2024 - 01/2002
21	Infections 03/2024 - 01/2015
20	Ischemic Stroke 02/2024 - 05/2004
20	Esophageal Squamous Cell Carcinoma 01/2024 - 10/2007
19	Stroke (Strokes) 02/2024 - 10/2002
16	Esophageal Neoplasms (Esophageal Cancer) 04/2024 - 01/2012
15	Ischemia 05/2024 - 01/2002
14	Carcinogenesis 11/2023 - 01/2012
13	Fibrosis (Cirrhosis) 07/2023 - 10/2016
13	Hemorrhage 05/2023 - 03/2010
11	Brain Ischemia (Cerebral Ischemia) 01/2023 - 12/2003
9	Reperfusion Injury 01/2023 - 01/2002
9	Leukemia 01/2023 - 01/2010
9	Alzheimer Disease (Alzheimer's Disease) 11/2022 - 05/2004
8	Lung Neoplasms (Lung Cancer) 09/2023 - 03/2016
8	Breast Neoplasms (Breast Cancer) 10/2022 - 02/2012
7	Neoplasm Metastasis (Metastasis) 04/2024 - 01/2012
7	COVID-19 04/2024 - 01/2020
7	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2023 - 03/2016
7	Transient Ischemic Attack 06/2014 - 05/2004
6	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 11/2012 - 07/2003
5	Liver Neoplasms (Liver Cancer) 11/2023 - 08/2013
5	Hepatocellular Carcinoma (Hepatoma) 11/2023 - 02/2013
5	Carcinoma (Carcinomatosis) 11/2023 - 01/2010
5	Infarction (Infarctions) 12/2017 - 01/2002
4	Pain (Aches) 01/2023 - 01/2014
4	Wounds and Injuries (Trauma) 02/2022 - 01/2002
4	Hypertension (High Blood Pressure) 12/2021 - 01/2013
4	Hypoxia (Hypoxemia) 01/2020 - 04/2012
4	Glioma (Gliomas) 10/2017 - 11/2008
3	Brain Edema (Cerebral Edema) 03/2024 - 12/2012
3	Brain Injuries (Brain Injury) 03/2024 - 01/2002
3	Nervous System Diseases (Neurological Disorders) 02/2024 - 01/2012
3	Rhabdomyolysis 01/2024 - 01/2017
3	Cardiovascular Diseases (Cardiovascular Disease) 12/2023 - 01/2018
3	Colitis 11/2023 - 02/2008
3	Stomach Neoplasms (Stomach Cancer) 01/2023 - 01/2019
3	Necrosis 01/2023 - 04/2005
3	Myasthenia Gravis 01/2023 - 01/2022

Drug/Important Bio-Agent (IBA)

41	Biomarkers (Surrogate Marker)IBA 03/2024 - 01/2010
34	Proteins (Proteins, Gene)FDA Link 04/2024 - 05/2004
17	MicroRNAs (MicroRNA)IBA 08/2021 - 01/2012
15	Glucose (Dextrose)FDA LinkGeneric 04/2024 - 04/2012
13	Estrogens (Estrogen)FDA Link 09/2017 - 01/2002
11	Neuroprotective AgentsIBA 01/2017 - 07/2003
10	CytokinesIBA 01/2024 - 01/2002
9	PolyaminesIBA 01/2018 - 01/2011
8	NitrosaminesIBA 01/2024 - 11/2019
8	Messenger RNA (mRNA)IBA 11/2023 - 10/2007
8	Therapeutic UsesIBA 09/2023 - 05/2004
7	PlatinumIBA 01/2023 - 03/2013
7	Oxaliplatin (Eloxatin)FDA LinkGeneric 06/2017 - 03/2013
6	Transcription Factors (Transcription Factor)IBA 05/2024 - 08/2014
6	Rituximab (Mabthera)FDA Link 04/2024 - 10/2019
6	Indicators and Reagents (Reagents)IBA 11/2023 - 01/2020
5	LipidsIBA 12/2023 - 07/2017
5	EnzymesIBA 11/2023 - 01/2010
5	AlbuminsIBA 09/2023 - 05/2020
5	DNA (Deoxyribonucleic Acid)IBA 03/2023 - 01/2013
5	SteroidsIBA 05/2021 - 12/2003
5	Estradiol (Delestrogen)FDA LinkGeneric 01/2021 - 12/2003
5	CollagenIBA 01/2021 - 01/2013
5	Daunorubicin (Cerubidine)FDA LinkGeneric 01/2019 - 01/2011
5	glecaprevir and pibrentasvirIBA 01/2018 - 01/2017
4	Interleukin-6 (Interleukin 6)IBA 03/2024 - 01/2018
4	SphingolipidsIBA 01/2024 - 07/2019
4	Drinking WaterIBA 01/2024 - 11/2019
4	IronIBA 01/2024 - 02/2010
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2023 - 01/2018
4	cyanoginosin LR (microcystin LR)IBA 12/2023 - 10/2022
4	Phospholipids (Phosphatides)FDA LinkGeneric 09/2023 - 04/2013
4	Fibrinogen (Factor I)FDA Link 02/2023 - 11/2012
4	Air Pollutants (Pollutants, Air)IBA 01/2023 - 01/2021
4	Retinaldehyde (Retinal)IBA 05/2021 - 07/2003
4	3' Untranslated Regions (3' UTR)IBA 02/2019 - 11/2009
4	Caspase 3 (Caspase-3)IBA 01/2019 - 06/2008
4	AntibodiesIBA 01/2018 - 02/2010
4	glecaprevirIBA 01/2018 - 10/2016
4	Matrix Metalloproteinases (MMPs)IBA 04/2011 - 01/2002
3	CateninsIBA 05/2024 - 11/2023
3	Glutamic Acid (Glutamate)FDA Link 02/2024 - 01/2002
3	MetalsIBA 01/2024 - 01/2022
3	HDL LipoproteinsIBA 01/2024 - 03/2016
3	LigandsIBA 12/2023 - 11/2007
3	Tryptophan (L-Tryptophan)FDA Link 11/2023 - 10/2020
3	Untranslated RNA (Noncoding RNA)IBA 11/2023 - 01/2018
3	RNA (Ribonucleic Acid)IBA 11/2023 - 12/2016
3	TabletsIBA 09/2023 - 10/2020
3	Brain-Derived Neurotrophic Factor (BDNF)IBA 02/2023 - 01/2022
3	CopperIBA 02/2023 - 12/2021
3	Triglycerides (Triacylglycerol)IBA 01/2023 - 01/2020
3	Morphine (MS Contin)FDA LinkGeneric 01/2023 - 01/2014
3	Peptides (Polypeptides)IBA 10/2022 - 01/2018

Therapy/Procedure

45	Therapeutics 01/2024 - 01/2002
13	Drug Therapy (Chemotherapy) 12/2023 - 01/2011
8	Chinese Traditional Medicine (Traditional Chinese Medicine) 09/2023 - 04/2013
4	Stents 02/2022 - 03/2019
4	Aftercare (After-Treatment) 01/2019 - 01/2012
3	Thrombectomy 10/2022 - 01/2021